Sleep Impairment and Coping Style in Diabetes (Diabetesleep)

This study has been completed.
Sponsor:
Information provided by:
Istanbul University
ClinicalTrials.gov Identifier:
NCT01343446
First received: April 26, 2011
Last updated: April 27, 2011
Last verified: April 2011
  Purpose

To examine the effect of sleep impairment on coping style of patients with diabetes


Condition
Obesity
Sleep Disorders
Coping Skills

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Sleep Impairment Can Influence The Coping Style Of Patients With Diabetes

Resource links provided by NLM:


Further study details as provided by Istanbul University:

Primary Outcome Measures:
  • Coping style of Patients with Diabetes suffer from Sleep Disorder [ Time Frame: Up to 1 week (Patients at follow-up) ] [ Designated as safety issue: Yes ]
    Patients with diabetes had filled the Epworth Sleepiness Scale and Coping styles ınventory


Enrollment: 105
Study Start Date: February 2011
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Patients with Diabetes
Patients with diabetes suffer from sleep impairment or not

Detailed Description:

Abstract Objective: To examine the effect of sleep impairment on coping style of patients with diabetes Research Design and Methods: A total of 105 patients (40 male, 65 female) with diabetes mellitus were recruited from outpatient diabetic clinics in 2011 February. All patients were asked to fill the sociodemographic inquiry, Epworth Sleepiness Scale and Coping Style Inventory.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Followed-up in Cerrahpasa Clinics of Diabetes Patients with diabetes Patients with/without diabetic complication Patients suffer from sleep impairment

Criteria

Inclusion Criteria:

- Patients with diabetes longer than 6 months

Exclusion Criteria:

- Complications as a congestive heart failure, chronic renal failure

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01343446

Locations
Turkey
Diabetes and Metabolism Outpatients Clinic of Cerrahpasa School of Medicine
Istanbul, Turkey, 34098
Sponsors and Collaborators
Istanbul University
Investigators
Study Director: Murat Emül, Assoc.Prof. Department of Psychiatry, Cerrahpasa School of Medicine
  More Information

Publications:
Responsible Party: Istanbul University, Cerrahpasa School of Medicine
ClinicalTrials.gov Identifier: NCT01343446     History of Changes
Other Study ID Numbers: Cer-Met-A2
Study First Received: April 26, 2011
Last Updated: April 27, 2011
Health Authority: Turkey: Ethics Committee

Keywords provided by Istanbul University:
Sleep impairment, Coping Style, Diabetes Mellitus

Additional relevant MeSH terms:
Sleep Disorders
Parasomnias
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Mental Disorders

ClinicalTrials.gov processed this record on September 29, 2014